The European court rules on the paroxetine pay-for-delay dispute

The long-running dispute over agreements to settle patent litigation between innovator company GSK and a series of generic producers has now reached the CJEU.

Mills & Reeve life sciences lead, James Fry, considers what this ruling might mean for your patent strategy here.

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.

Posted by


Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R


Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.


Mills & Reeve system for employees.